A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia

Clinical trial NCT03195491 · COMPLETED

Trial details

NCT number: NCT03195491
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer Non-Small Cell Lung Cancer

Start date: 2017-12-25
Primary completion: 2021-06-08
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.